Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus-Reference-Cited by-同舟云学术

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Published:2013-04 Issue:7446 Volume:496 Page:469-476
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Liao Hua-Xin, ,Lynch Rebecca,Zhou Tongqing,Gao Feng,Alam S. Munir,Boyd Scott D.,Fire Andrew Z.,Roskin Krishna M.,Schramm Chaim A.,Zhang Zhenhai,Zhu Jiang,Shapiro Lawrence,Mullikin James C.,Gnanakaran S.,Hraber Peter,Wiehe Kevin,Kelsoe Garnett,Yang Guang,Xia Shi-Mao,Montefiori David C.,Parks Robert,Lloyd Krissey E.,Scearce Richard M.,Soderberg Kelly A.,Cohen Myron,Kamanga Gift,Louder Mark K.,Tran Lillian M.,Chen Yue,Cai Fangping,Chen Sheri,Moquin Stephanie,Du Xiulian,Joyce M. Gordon,Srivatsan Sanjay,Zhang Baoshan,Zheng Anqi,Shaw George M.,Hahn Beatrice H.,Kepler Thomas B.,Korber Bette T. M.,Kwong Peter D.,Mascola John R.,Haynes Barton F.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature12053.pdf

Reference71 articles.

1. Walker, L. M. et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326, 285–289 (2009)

2. Walker, L. M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466–470 (2011)

3. Burton, D. R., Poignard, P., Stanfield, R. L. & Wilson, I. A. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337, 183–186 (2012)

4. Kwong, P. D. & Mascola, J. R. Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. Immunity 37, 412–425 (2012)

5. Wu, X. et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856–861 (2010)

Cited by 933 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

2. Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1;Virology;2024-09

3. Flavivirus cross-reactivity: Insights into e-protein conservancy, pre-existing immunity, and co-infection;The Microbe;2024-09

4. Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site;Science Immunology;2024-08-30

5. Modelling HIV-1 control and remission;npj Systems Biology and Applications;2024-08-08